XLRN

Acceleron Pharma Inc. News Headlines

$34.83
*  
0.55
1.6%
Get XLRN Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading XLRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months
10/31/2014 8:59:00 AM - Seeking Alpha


Acceleron Pharma Host''s Beta-thalassemia Educational Webcast At 12:30 PM ET
10/17/2014 11:30:00 AM - RTT News


Acceleron Pharma Host's Beta-thalassemia Educational Webcast At 12:30 PM ET
10/17/2014 11:30:00 AM - RTT News


A Quick Look at Celgene Corporation's Drug Development Pipeline
10/16/2014 8:35:03 AM - Motley Fool


Sector Update: Health-care Stocks Higher Pre-Bell
10/14/2014 7:40:59 AM - MT Newswires


Sector Update: Health Care
10/14/2014 7:37:10 AM - MT Newswires


Ocera Therapeutics Finally Ready To Reward Investors
10/1/2014 12:32:00 PM - Seeking Alpha


Acceleron Pharma To Present In Leerink Roundtable Conference At 10:15 AM ET
10/1/2014 9:15:00 AM - RTT News


Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape
9/24/2014 8:39:00 AM - Zacks.com


Celgene's Pomalyst Data at European Hematology Association Shows Promise - Analyst Blog
6/17/2014 12:40:00 PM - Zacks.com


Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha


Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape
4/3/2014 8:39:01 AM - Zacks.com


Standard Review for Merck's V503 - Analyst Blog
2/25/2014 6:20:01 PM - Zacks.com


Orphan Drug Status for XOMA's Gevokizumab - Analyst Blog
2/25/2014 5:40:01 PM - Zacks.com


Progenics to Raise Funds - Analyst Blog
2/24/2014 12:10:01 PM - Zacks.com


Biotech Boomlet Set To Smash IPO Record For Two-Week Period
2/2/2014 5:42:00 AM - Seeking Alpha


Biotech boomlet set to smash IPO record for two-week period
1/30/2014 5:36:48 PM - Renaissance Capital


Acceleron Pharma (XLRN) Soars: Stock Up 9.8% - Tale of the Tape
1/23/2014 9:39:01 AM - Zacks.com


Can the Rally in Acceleron Pharma (XLRN) Shares Continue? - Tale of the Tape
1/21/2014 7:25:01 AM - Zacks.com


Why Acceleron (XLRN) Has A Bright Short-Term Future? - Tale of the Tape
1/20/2014 8:30:01 AM - Zacks.com


Pipeline Update from BioDelivery Sciences - Analyst Blog
1/14/2014 6:50:01 PM - Zacks.com


Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
12/30/2013 1:30:00 AM - Seeking Alpha


Celgene Buys Shares of Acceleron Pharma, and KAR Auction Services Sees Major Sale
9/27/2013 10:06:00 AM - Minyanville


Cramer's Mad Money - 10 Stocks Money Managers Will Be Buying (9/26/13)
9/27/2013 6:10:00 AM - Seeking Alpha


US IPO Recap: Blazing debuts for software trio FireEye, Rocket Fuel and Benefitfocus
9/23/2013 8:22:47 AM - Renaissance Capital